Literature DB >> 1928067

Urinary porphyrin excretion in normal children and adults.

K E Bloom1, E F Zaider, L J Morledge, M B Poh-Fitzpatrick.   

Abstract

The relationship of random urinary porphyrin and creatinine values as functions of age and sex was examined in a normal population. Total urinary porphyrin was measured by a solvent extraction technique, while urinary creatinine was evaluated by an alkaline picrate method. Random urine specimens from 120 healthy patients (81 children and 39 adults) were evaluated. In both pediatric and adult populations, a strong correlation was found between urinary concentrations of porphyrin and creatinine (r = 0.7, P less than 0.0001). Urinary porphyrin excretion in mumol/mol creatinine (micrograms/g) was inversely related to both age (r = -0.59, P less than 0.0001) and weight (r = -0.61, P less than 0.0001) until approximately 9 years of age or 30 kg. Urinary porphyrin excretion in children 9 to 18 years of age was lower than that of younger children (P less than 0.0001) and approached adult values. Sex was not found to be a factor until 9 to 18 years of age, when females had higher urinary creatinine concentrations (P less than 0.05), but lower urinary porphyrin excretions (P less than 0.05) than similarly aged males. The converse was observed when similar values of adult women were compared with those of adult men. Men also had higher urinary porphyrin concentrations than women (P less than 0.01). Men had increased urinary creatinine concentration (P less than 0.05) and decreased porphyrin excretion ratios (P less than 0.05) when compared with males 9 to 18 years of age. Women had significantly lower urinary creatinine (P less than 0.001) and porphyrin (P less than 0.001) concentrations than females 9 to 18 years of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928067     DOI: 10.1016/s0272-6386(12)80117-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  ACP Best Practice No 165: front line tests for the investigation of suspected porphyria.

Authors:  A C Deacon; G H Elder
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

2.  Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.

Authors:  Eliane Sardh; Lillan Rejkjaer; Dan E H Andersson; Pauline Harper
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Urinary porphyrin excretion in normal children and adolescents.

Authors:  James S Woods; Michael D Martin; Brian G Leroux; Timothy A DeRouen; Mario F Bernardo; Henrique S Luis; Jorge G Leitão; P Lynne Simmonds; Tessa C Rue
Journal:  Clin Chim Acta       Date:  2009-04-24       Impact factor: 3.786

4.  Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene.

Authors:  Dolores Ozalla; Carmen Herrero; Núria Ribas-Fitó; Jordi To-Figueras; Agustí Toll; Maria Sala; Joan Grimalt; Xavier Basagaña; Màrius Lecha; Jordi Sunyer
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

5.  Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.

Authors:  Mattias Lissing; Daphne Vassiliou; Ylva Floderus; Pauline Harper; Matteo Bottai; Marianna Kotopouli; Hannes Hagström; Eliane Sardh; Staffan Wahlin
Journal:  J Intern Med       Date:  2022-03-02       Impact factor: 13.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.